CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 5.3: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
10.51%
Annual Rate
HKD 0.20Paid semi-annual
Payout Ratio
86.3%High
Next Ex-Dividend
Sep 7, 2026
The reported statements, read against the company's own industry.
The statements on file don't all cover the same year: income statement FY2025, balance sheet FY2026, cash-flow statement FY2026. Each figure below is labelled with the year it comes from.
Financials view
Market Capitalization
2.37BHKD302.29M · vs all stocks (USD)
Trailing P/E
7.30xRevenue (TTM)
834.63MHKD106.45M · vs all stocks (USD)
Profit Margin
24.09%Beta
0.1910xvs all stocks
52-Week Change
-39.77%vs all stocks
Forward Annual Dividend Yield
10.51%vs all stocks
Market Capitalization
2.37BHKD302.29M · vs all stocks (USD)
Enterprise Value
1.78BHKD226.90M · vs all stocks (USD)
Trailing P/E
7.30xForward P/E
6.60xPrice to Sales (TTM)
1.79xPrice to Book (MRQ)
1.38xEnterprise to Revenue
2.13xEnterprise to EBITDA
6.07xProfit Margin
24.09%Operating Margin
29.21%Return on Assets (TTM)
9.98%Return on Equity (TTM)
18.33%Revenue (TTM)
834.63MHKD106.45M · vs all stocks (USD)
Revenue per Share (TTM)
1.02HKDUpdated Aug 20, 2026Quarterly Revenue Growth
5.60%Gross Profit (TTM)
465.54MHKD59.37M · vs all stocks (USD)
EBITDA (TTM)
314.21MHKD40.07M · vs all stocks (USD)
Net Income (TTM)
201.09MHKD25.65M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-15.10%Operating Cash Flow (TTM)
162.40MHKD20.71M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
101.04MHKD12.89M · vs all stocks (USD)
Forward Annual Dividend Rate
0.1950HKDUpdated Aug 20, 2026Forward Annual Dividend Yield
10.51%vs all stocks
Trailing Annual Dividend Rate
0.2125HKDUpdated Aug 20, 2026Trailing Annual Dividend Yield
11.46%vs all stocks
Payout Ratio
86.28%Minority Interest (Equity)
50.87MHKDFY2026 · Mar 31, 2026Revenue
782.29MHKDFY2025 · Mar 31, 2025Cost of Goods Sold
368.58MHKDFY2025 · Mar 31, 2025Gross Profit
413.71MHKDFY2025 · Mar 31, 2025Operating Income
228.80MHKD29.18M · vs all stocks (USD)
Pre-tax Income
241.67MHKDFY2025 · Mar 31, 2025Income Tax Expense
38.98MHKDFY2025 · Mar 31, 2025Net Income
202.69MHKDFY2025 · Mar 31, 2025EBIT
246.13MHKDFY2025 · Mar 31, 2025EBITDA (Income Statement)
297.52MHKDFY2025 · Mar 31, 2025Selling, General & Administrative
185.74MHKDFY2025 · Mar 31, 2025Non-operating Interest Income
1.57MHKDFY2025 · Mar 31, 2025Non-operating Interest Expense
4.46MHKDFY2025 · Mar 31, 2025EPS (Basic)
0.2408HKDFY2025 · Mar 31, 2025EPS (Diluted)
0.2408HKDFY2025 · Mar 31, 2025Basic Shares Outstanding
819.19MSharesFY2025 · Mar 31, 2025Diluted Shares Outstanding
819.19MSharesFY2025 · Mar 31, 2025Minority Interests (P&L)
-5.43MHKDFY2025 · Mar 31, 2025Preferred Stock Dividends
0.00HKDFY2025 · Mar 31, 2025Operating Cash Flow
168.39MHKDFY2026 · Mar 31, 2026Free Cash Flow
135.09MHKDFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
119.94MHKDFY2026 · Mar 31, 2026Starting Profit (CF Statement)
252.15MHKDFY2026 · Mar 31, 2026Stock-based Compensation
18.42MHKDFY2026 · Mar 31, 2026Other Non-cash Items
10.89MHKDFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-119.35MHKDFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
6.28MHKDFY2026 · Mar 31, 2026Capital Expenditures
-33.30MHKDFY2026 · Mar 31, 2026Net Acquisitions
-126.82MHKDFY2026 · Mar 31, 2026Purchase of Investments
0.00HKDFY2026 · Mar 31, 2026Sale of Investments
0.00HKDFY2026 · Mar 31, 2026Net Investing Cash Flow
-160.13MHKDFY2026 · Mar 31, 2026Long-term Debt Issuance
538.17MHKDFY2026 · Mar 31, 2026Long-term Debt Payments
-322.99MHKDFY2026 · Mar 31, 2026Common Stock Repurchase
0.00HKDFY2026 · Mar 31, 2026Common Dividends Paid
-173.80MHKDFY2026 · Mar 31, 2026Other Financing Charges
-97.43MHKDFY2026 · Mar 31, 2026Net Financing Cash Flow
-56.84MHKDFY2026 · Mar 31, 2026Shares Outstanding
819.80MSharesUpdated Aug 20, 2026Float Shares
216.53MSharesUpdated Aug 20, 2026% Held by Insiders
73.39%vs all stocks
% Held by Institutions
0.26%vs all stocks
Total Cash (MRQ)
173.98MHKD22.19M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.2120HKDUpdated Aug 20, 2026Total Debt (MRQ)
393.72MHKD50.22M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3481xCurrent Ratio (MRQ)
1.90xBook Value per Share (MRQ)
1.32HKDUpdated Aug 20, 2026Total Assets
1.76BHKD224.81M · vs all stocks (USD)
Total Current Assets
488.31MHKDFY2026 · Mar 31, 2026Total Liabilities
631.64MHKDFY2026 · Mar 31, 2026Total Non-current Assets
1.27BHKDFY2026 · Mar 31, 2026Total Non-current Liabilities
374.11MHKDFY2026 · Mar 31, 2026Total Current Liabilities
257.54MHKDFY2026 · Mar 31, 2026Cash
119.94MHKDFY2026 · Mar 31, 2026Cash & Cash Equivalents
119.94MHKDFY2026 · Mar 31, 2026Accounts Receivable
229.23MHKDFY2026 · Mar 31, 2026Inventory
80.07MHKDFY2026 · Mar 31, 2026Accounts Payable
19.35MHKDFY2026 · Mar 31, 2026Short-term Debt
134.49MHKDFY2026 · Mar 31, 2026Long-term Debt
259.23MHKDFY2026 · Mar 31, 2026Common Stock (Book)
8.20MHKDFY2026 · Mar 31, 2026Retained Earnings
480.56MHKDFY2026 · Mar 31, 2026Total Shareholders' Equity
1.13BHKD144.25M · vs all stocks (USD)
52-Week Low
1.81HKDUpdated Aug 20, 202652-Week High
3.15HKDUpdated Aug 20, 202652-Week Change
-39.77%vs all stocks
Beta
0.1910xvs all stocks
50-Day MA
2.04HKDUpdated Aug 20, 2026200-Day MA
2.52HKDUpdated Aug 20, 2026Avg 10-Day Volume
296.20KSharesUpdated Aug 20, 2026Avg 30-Day Volume
308.73KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.2500HKDUpdated Aug 20, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Operating income rose four years, with small depreciation on a capital-heavy balance sheet.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.3: safe zoneNotable
Altman Z-Score: 5.30
High earnings qualityNotable
Earnings Quality Score: 0.96
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
908 Devices Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hikal Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Essex Bio-Technology Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Immuneering Corporation
Tier 1ProductionApproval-Gated PipelineRule
Foghorn Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Anhui Huangshan Capsule Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Neumora Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Tanvex Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Il Dong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
AP Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
H. Lundbeck A/S
2 interpretationsMulti-Year Revenue, Profit, And Income GrowthRising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Chipotle Mexican Grill, Inc.
2 interpretationsMulti-Year Revenue, Profit, And Income GrowthRising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Novartis AG
2 interpretationsMulti-Year Revenue, Profit, And Income GrowthRising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet